S-1: Avant Technologies Files for Resale of 40 Million Shares of Common Stock

Avant Technologies Inc. has filed a registration statement for the resale of up to 40,000,000 shares of its common stock by a selling stockholder.

Summary

• Avant Technologies Inc. has filed a Form S-1 registration statement with the SEC.
• The registration statement pertains to the resale of up to 40,000,000 shares of common stock held by a selling stockholder, GHS Investments LLC.
• These shares, if issued, would represent approximately 29.14% of the company's existing issued and outstanding shares as of February 28, 2025.
• The company is offering the shares at a price equal to 80% of the market price on the Put Date for a period of two years.
• If all shares are purchased, the gross proceeds to the company will be $20,000,000.
• The funds raised will be used in accordance with the company's intended Use of Proceeds.
• The company acknowledges that investing in its common stock involves a high degree of risk.
• The company's business strategy includes acquiring, creating, and developing innovative technologies utilizing artificial intelligence (AI).
• The company's key acquisitions include Avant! AI, InstantFAME, and a Joint Venture and License Agreement with Ainnova Tech Inc. (AINN).
• The company had a net loss of $1,606,187 for the nine months ended December 31, 2024 and net loss of $2,128,475 for the year ended March 31, 2024.
• The company had a stockholders deficit of $2,135,600 and an accumulated deficit of $4,582,582 as of December 31, 2024.
• The company intends to use approximately 60% of the proceeds to fund the operations and expansion of the Ainnova JV, 30% for general working capital, and 10% for research and development.

Sentiment

Score: 4

Explanation: The document presents a mixed sentiment. While there are positive aspects such as the potential capital raise and strategic acquisitions, the company's financial performance, including net losses and accumulated deficit, raises concerns. The high degree of risk associated with investing in the company's common stock further contributes to a cautious sentiment.

Positives

• The company anticipates raising $20,000,000 if all shares are purchased.
• The company has a joint venture with Ainnova Tech Inc. to develop AI-powered healthcare technologies.
• The company has acquired Avant! AI and InstantFAME to enhance its AI capabilities.

Negatives

• The company has a limited operating history in an evolving industry.
• The company's results of operations have not resulted in profitability.
• The company has not generated positive cash flow from operations.
• The company had a net loss of $1,606,187 for the nine months ended December 31, 2024 and net loss of $2,128,475 for the year ended March 31, 2024.
• The company had a stockholders deficit of $2,135,600 and an accumulated deficit of $4,582,582 as of December 31, 2024.

Risks

• The company has a limited operating history in an evolving industry, making it difficult to evaluate future prospects.
• The company's limited operating history makes it difficult to forecast future results.
• The company's results of operations have not resulted in profitability, and it may not be able to achieve profitability going forward.
• The company has not generated positive cash flow from operations, and its ability to generate positive cash flow is uncertain.
• The company will require additional capital to support business growth, and this capital might not be available on acceptable terms, if at all.
• The company depends upon key personnel and needs additional personnel.
• There is currently a limited public market for the company's common stock.
• The company's stock price and trading volume may be volatile, which could result in substantial losses for stockholders.
• Shares eligible for future sale may adversely affect the market for the company's common stock.
• Investors may experience future dilution as a result of future equity offerings.
• Penny stock regulations may impose certain restrictions on marketability of the company's securities.

Future Outlook

The company intends to continue making investments to support its business growth and will require additional funds to respond to business challenges, including the need to develop new features and products or enhance existing products, improve its operating infrastructure or acquire complementary businesses and technologies.

Industry Context

The company operates in the technology sector, specifically focusing on artificial intelligence (AI) and IT consulting services. The company's strategy involves acquiring and developing innovative technologies, which is a common approach in the rapidly evolving tech industry. The company's joint venture with Ainnova Tech Inc. reflects a trend of collaboration and partnerships to leverage expertise and resources in the healthcare AI space.

Comparison to Industry Standards

• The document does not provide enough information to make a detailed comparison to industry standards.
• Without specific revenue figures, growth rates, or profitability metrics, it's difficult to benchmark Avant Technologies against its competitors.
• Companies like C3.ai, Palantir, and UiPath are key players in the AI space, but a direct comparison would require more detailed financial and operational data.
• Similarly, comparing the company's IT consulting services to firms like Accenture, IBM, or Tata Consultancy Services would necessitate more specific information about the company's service offerings and client base.

Related Party Transactions

• As of December 31, 2024, our secretary, Natalija Tunevic, has loaned to the Company $114,328.
• As of December 31, 2024, our director, Vitalis Racius, has loaned to the Company $83,387.
• As of December 31, 2024, our shareholder, Marieta Seiranova, has loaned to the Company $57,436.
• As of December 31, 2024, our shareholder, Mehrabian Investments LLC, has loaned to the Company $30,000.
• As of December 31, 2024, our shareholder, IGOR 1 CORP, has loaned to the Company $131,383.
• The Companys subsidiary Thynews Tech LLC received $124,590 as advances from related parties as of December 31, 2024.

Stakeholder Impact

• Shareholders face a high degree of risk due to the company's limited operating history, lack of profitability, and potential stock dilution.
• Employees may be affected by the company's ability to secure additional capital and maintain operations.
• Customers may benefit from the company's development of innovative AI solutions, but the company's financial instability could impact its ability to deliver on its promises.
• Suppliers and creditors face the risk of non-payment due to the company's negative cash flow and accumulated deficit.

Next Steps

• The company will use its best efforts to file with the SEC a Registration Statement registering the Shares.
• The company will allocate approximately 60% of the proceeds to fund the operations and expansion of the Ainnova JV, 30% for general working capital, and 10% for research and development.

Key Dates